Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
2017 · New England Journal of Medicine · 1,136 citations
https://doi.org/10.1056/nejmoa1611977
C
Christopher J. O’Callaghan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
189
Papers
13.0K
Citations
43
h-index
88
i10-index
Christopher J. O’Callaghan is an academic researcher from Queen's University. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Gastric Cancer Management and Outcomes. The author has an h-index of 43, co-authored 161 publications.
Papers by this author
worksRational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer
2004 · JNCI Journal of the National Cancer Institute · 509 citations
https://doi.org/10.1093/jnci/djh131
Risk maps for range expansion of the Lyme disease vector, Ixodes scapularis, in Canada now and with climate change
2008 · International Journal of Health Geographics · 248 citations
https://doi.org/10.1186/1476-072x-7-24
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
2025 · New England Journal of Medicine · 134 citations
https://doi.org/10.1056/nejmoa2502760
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
2013 · British Journal of Cancer · 94 citations
https://doi.org/10.1038/bjc.2013.753
Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01)
2017 · The Lancet. Gastroenterology & hepatology · 93 citations
https://doi.org/10.1016/s2468-1253(17)30363-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat